<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34423767</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>31</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>04</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1080-6059</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>9</Issue><PubDate><Year>2021</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Emerging infectious diseases</Title><ISOAbbreviation>Emerg Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Seroprevalence and Virologic Surveillance of Enterovirus 71 and Coxsackievirus A6, United Kingdom, 2006-2017.</ArticleTitle><Pagination><StartPage>2261</StartPage><EndPage>2268</EndPage><MedlinePgn>2261-2268</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3201/eid2709.204915</ELocationID><Abstract><AbstractText>Enterovirus A71 (EV-A71) and coxsackievirus A6 (CVA6) cause hand, foot and mouth disease (HFMD) and are occasionally linked to severe neurologic complications and large outbreaks worldwide. We estimated EV-A71 and CVA6 seroprevalence using cross-sectional age-stratified samples collected in 2006, 2011, and 2017. Seroprevalences of EV-A71 and CVA6 increased from 32% and 54% at 6-11 months to &gt;75% by 10 years of age. Antibody titers declined after 20 years, which could indicate infrequent re-exposure in older populations. Age profiles for acquiring infections and mean titers were comparable in the 3 testing years, despite the marked increase in incidence of CVA6-related HFMD from 2010. The uncoupling of changes in disease severity from the infection kinetics of CVA6 as we inferred from the seroprevalence data, rather than incidence of infection over the 11-year study period, provides further evidence for a change in its pathogenicity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kamau</LastName><ForeName>Everlyn</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Dung</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Celma</LastName><ForeName>Cristina</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Blomqvist</LastName><ForeName>Soile</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Horby</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Simmonds</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Harvala</LastName><ForeName>Heli</ForeName><Initials>H</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Emerg Infect Dis</MedlineTA><NlmUniqueID>9508155</NlmUniqueID><ISSNLinking>1080-6040</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="Y">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016036" MajorTopicYN="N">Seroepidemiologic Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CVA6</Keyword><Keyword MajorTopicYN="N">EV-A71</Keyword><Keyword MajorTopicYN="N">England</Keyword><Keyword MajorTopicYN="N">United Kingdom</Keyword><Keyword MajorTopicYN="N">antibodies</Keyword><Keyword MajorTopicYN="N">coxsackievirus</Keyword><Keyword MajorTopicYN="N">enterovirus</Keyword><Keyword MajorTopicYN="N">exposure</Keyword><Keyword MajorTopicYN="N">hand foot and mouth disease</Keyword><Keyword MajorTopicYN="N">immunity</Keyword><Keyword MajorTopicYN="N">seroprevalence</Keyword><Keyword MajorTopicYN="N">viruses</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>23</Day><Hour>8</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34423767</ArticleId><ArticleId IdType="pmc">PMC8386771</ArticleId><ArticleId IdType="doi">10.3201/eid2709.204915</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aswathyraj S, Arunkumar G, Alidjinou EK, Hober D. Hand, foot and mouth disease (HFMD): emerging epidemiology and the need for a vaccine strategy. Med Microbiol Immunol (Berl). 2016;205:397&#x2013;407. 10.1007/s00430-016-0465-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00430-016-0465-y</ArticleId><ArticleId IdType="pubmed">27406374</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein M, Chong P. Is a multivalent hand, foot, and mouth disease vaccine feasible? Hum Vaccin Immunother. 2015;11:2688&#x2013;704. 10.1080/21645515.2015.1049780</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2015.1049780</ArticleId><ArticleId IdType="pmc">PMC4685682</ArticleId><ArticleId IdType="pubmed">26009802</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang LY, Lin HY, Gau SS, Lu CY, Hsia SH, Huang YC, et al. Enterovirus A71 neurologic complications and long-term sequelae. J Biomed Sci. 2019;26:57. 10.1186/s12929-019-0552-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-019-0552-7</ArticleId><ArticleId IdType="pmc">PMC6688366</ArticleId><ArticleId IdType="pubmed">31395054</ArticleId></ArticleIdList></Reference><Reference><Citation>Karrasch M, Fischer E, Scholten M, Sauerbrei A, Henke A, Renz DM, et al. A severe pediatric infection with a novel enterovirus A71 strain, Thuringia, Germany. J Clin Virol. 2016;84:90&#x2013;5. 10.1016/j.jcv.2016.09.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2016.09.007</ArticleId><ArticleId IdType="pubmed">27771495</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassel C, Mirand A, Lukashev A, TerletskaiaLadwig E, Farkas A, Schuffenecker I, et al. Transmission patterns of human enterovirus 71 to, from and among European countries, 2003 to 2013. Euro Surveill. 2015;20:30005. 10.2807/1560-7917.ES.2015.20.34.30005</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2015.20.34.30005</ArticleId><ArticleId IdType="pubmed">26530407</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngangas ST, Lukashev A, Jugie G, Ivanova O, Mansuy JM, Mengelle C, et al. Multirecombinant enterovirus A71 subgenogroup C1 isolates associated with neurologic disease, France, 2016&#x2013;2017. Emerg Infect Dis. 2019;25:1204&#x2013;8. 10.3201/eid2506.181460</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2506.181460</ArticleId><ArticleId IdType="pmc">PMC6537711</ArticleId><ArticleId IdType="pubmed">31107209</ArticleId></ArticleIdList></Reference><Reference><Citation>Casas-Alba D, de Sevilla MF, Valero-Rello A, Fortuny C, Garc&#xed;a-Garc&#xed;a JJ, Ortez C, et al. Outbreak of brainstem encephalitis associated with enterovirus-A71 in Catalonia, Spain (2016): a clinical observational study in a children&#x2019;s reference centre in Catalonia. Clin Microbiol Infect. 2017;23:874&#x2013;81. 10.1016/j.cmi.2017.03.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2017.03.016</ArticleId><ArticleId IdType="pubmed">28344164</ArticleId></ArticleIdList></Reference><Reference><Citation>Antona D, Kossorotoff M, Schuffenecker I, Mirand A, Leruez-Ville M, Bassi C, et al. Severe paediatric conditions linked with EV-A71 and EV-D68, France, May to October 2016. Euro Surveill. 2016;21:21. 10.2807/1560-7917.ES.2016.21.46.30402</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2016.21.46.30402</ArticleId><ArticleId IdType="pmc">PMC5144948</ArticleId><ArticleId IdType="pubmed">27918268</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis. 2010;10:778&#x2013;90. 10.1016/S1473-3099(10)70194-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Bubba L, Broberg EK, Jasir A, Simmonds P, Harvala H, Redlberger-Fritz M, et al.; Enterovirus study collaborators. Circulation of non-polio enteroviruses in 24 EU and EEA countries between 2015 and 2017: a retrospective surveillance study. Lancet Infect Dis. 2020;20:350&#x2013;61. 10.1016/S1473-3099(19)30566-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(19)30566-3</ArticleId><ArticleId IdType="pubmed">31870905</ArticleId></ArticleIdList></Reference><Reference><Citation>Bian L, Wang Y, Yao X, Mao Q, Xu M, Liang Z. Coxsackievirus A6: a new emerging pathogen causing hand, foot and mouth disease outbreaks worldwide. Expert Rev Anti Infect Ther. 2015;13:1061&#x2013;71. 10.1586/14787210.2015.1058156</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14787210.2015.1058156</ArticleId><ArticleId IdType="pubmed">26112307</ArticleId></ArticleIdList></Reference><Reference><Citation>Anh NT, Nhu LNT, Van HMT, Hong NTT, Thanh TT, Hang VTT, et al. Emerging coxsackievirus A6 causing hand, foot and mouth disease, Vietnam. Emerg Infect Dis. 2018;24:654&#x2013;62. 10.3201/eid2404.171298</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2404.171298</ArticleId><ArticleId IdType="pmc">PMC5875260</ArticleId><ArticleId IdType="pubmed">29553326</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathes EF, Oza V, Frieden IJ, Cordoro KM, Yagi S, Howard R, et al. &#x201c;Eczema coxsackium&#x201d; and unusual cutaneous findings in an enterovirus outbreak. Pediatrics. 2013;132:e149&#x2013;57. 10.1542/peds.2012-3175</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2012-3175</ArticleId><ArticleId IdType="pmc">PMC4074616</ArticleId><ArticleId IdType="pubmed">23776120</ArticleId></ArticleIdList></Reference><Reference><Citation>Feder HM Jr, Bennett N, Modlin JF. Atypical hand, foot, and mouth disease: a vesiculobullous eruption caused by Coxsackie virus A6. Lancet Infect Dis. 2014;14:83&#x2013;6. 10.1016/S1473-3099(13)70264-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(13)70264-0</ArticleId><ArticleId IdType="pubmed">24287184</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PNA, Wang AD, Yin M, Lee CK, Archuleta S. Atypical hand, foot, and mouth disease: eczema coxsackium can also occur in adults. Lancet Infect Dis. 2014;14:1043. 10.1016/S1473-3099(14)70976-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(14)70976-4</ArticleId><ArticleId IdType="pubmed">25444404</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YJ, Chang SC, Tsao KC, Shih SR, Yang SL, Lin TY, et al. Comparative genomic analysis of coxsackievirus A6 strains of different clinical disease entities. PLoS One. 2012;7:e52432. 10.1371/journal.pone.0052432</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0052432</ArticleId><ArticleId IdType="pmc">PMC3530459</ArticleId><ArticleId IdType="pubmed">23300669</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaunt E, Harvala H, &#xd6;sterback R, Sreenu VB, Thomson E, Waris M, et al. Genetic characterization of human coxsackievirus A6 variants associated with atypical hand, foot and mouth disease: a potential role of recombination in emergence and pathogenicity. J Gen Virol. 2015;96:1067&#x2013;79. 10.1099/vir.0.000062</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.000062</ArticleId><ArticleId IdType="pmc">PMC4631059</ArticleId><ArticleId IdType="pubmed">25614593</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing W, Liao Q, Viboud C, Zhang J, Sun J, Wu JT, et al. Hand, foot, and mouth disease in China, 2008-12: an epidemiological study. Lancet Infect Dis. 2014;14:308&#x2013;18. 10.1016/S1473-3099(13)70342-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(13)70342-6</ArticleId><ArticleId IdType="pmc">PMC4035015</ArticleId><ArticleId IdType="pubmed">24485991</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinclair C, Gaunt E, Simmonds P, Broomfield D, Nwafor N, Wellington L, et al. Atypical hand, foot, and mouth disease associated with coxsackievirus A6 infection, Edinburgh, United Kingdom, January to February 2014. Euro Surveill. 2014;19:20745. 10.2807/1560-7917.ES2014.19.12.20745</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES2014.19.12.20745</ArticleId><ArticleId IdType="pubmed">24698138</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd6;sterback R, Vuorinen T, Linna M, Susi P, Hyypi&#xe4; T, Waris M. Coxsackievirus A6 and hand, foot, and mouth disease, Finland. Emerg Infect Dis. 2009;15:1485&#x2013;8. 10.3201/eid1509.090438</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1509.090438</ArticleId><ArticleId IdType="pmc">PMC2819858</ArticleId><ArticleId IdType="pubmed">19788821</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamau E, Harvala H, Blomqvist S, Nguyen D, Horby P, Pebody R, et al. Increase in enterovirus D68 infections in young children, United Kingdom, 2006&#x2013;2016. Emerg Infect Dis. 2019;25:1200&#x2013;3. 10.3201/eid2506.181759</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2506.181759</ArticleId><ArticleId IdType="pmc">PMC6537723</ArticleId><ArticleId IdType="pubmed">30855226</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyet LA, Thanh TT, Nhan LNT, Hong NTT, Nhu LNT, Van HMT, et al. Neutralizing antibodies against enteroviruses in patients with hand, foot and mouth disease. Emerg Infect Dis. 2020;26:298&#x2013;306. 10.3201/eid2602.190721</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2602.190721</ArticleId><ArticleId IdType="pmc">PMC6986819</ArticleId><ArticleId IdType="pubmed">31961293</ArticleId></ArticleIdList></Reference><Reference><Citation>Ang LW, Tay J, Phoon MC, Hsu JP, Cutter J, James L, et al. Seroepidemiology of coxsackievirus A6, coxsackievirus A16, and enterovirus 71 infections among children and adolescents in Singapore, 2008&#x2013;2010. PLoS One. 2015;10:e0127999. 10.1371/journal.pone.0127999</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0127999</ArticleId><ArticleId IdType="pmc">PMC4444285</ArticleId><ArticleId IdType="pubmed">26011735</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B, Wu P, Wu JT, Lau EH, Leung GM, Yu H, et al. Seroprevalence of enterovirus 71 antibody among children in China. Pediatr Infect Dis J. 2015;34:1399&#x2013;406. 10.1097/INF.0000000000000900</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000000900</ArticleId><ArticleId IdType="pmc">PMC4718881</ArticleId><ArticleId IdType="pubmed">26368058</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo ST, Chiang PS, Chao AS, Liou GY, Lin R, Lin TY, et al. Enterovirus 71 maternal antibodies in infants, Taiwan. Emerg Infect Dis. 2009;15:581&#x2013;4. 10.3201/1504.081550</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/1504.081550</ArticleId><ArticleId IdType="pmc">PMC2671432</ArticleId><ArticleId IdType="pubmed">19331737</ArticleId></ArticleIdList></Reference><Reference><Citation>Diedrich S, Weinbrecht A, Schreier E. Seroprevalence and molecular epidemiology of enterovirus 71 in Germany. Arch Virol. 2009;154:1139&#x2013;42. 10.1007/s00705-009-0413-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-009-0413-x</ArticleId><ArticleId IdType="pubmed">19506798</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Sanden SM, Koen G, van Eijk H, Koekkoek SM, de Jong MD, Wolthers KC. Prediction of protection against Asian enterovirus 71 outbreak strains by cross-neutralizing capacity of serum from Dutch donors, the Netherlands. Emerg Infect Dis. 2016;22:1562&#x2013;9. 10.3201/eid2209.151579</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2209.151579</ArticleId><ArticleId IdType="pmc">PMC4994357</ArticleId><ArticleId IdType="pubmed">27533024</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabenau HF, Richter M, Doerr HW. Hand, foot and mouth disease: seroprevalence of Coxsackie A16 and Enterovirus 71 in Germany. Med Microbiol Immunol (Berl). 2010;199:45&#x2013;51. 10.1007/s00430-009-0133-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00430-009-0133-6</ArticleId><ArticleId IdType="pubmed">19941005</ArticleId></ArticleIdList></Reference><Reference><Citation>Ooi EE, Phoon MC, Ishak B, Chan SH. Seroepidemiology of human enterovirus 71, Singapore. Emerg Infect Dis. 2002;8:995&#x2013;7. 10.3201/eid0809.010397</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid0809.010397</ArticleId><ArticleId IdType="pmc">PMC2732542</ArticleId><ArticleId IdType="pubmed">12194783</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran CB, Nguyen HT, Phan HT, Tran NV, Wills B, Farrar J, et al. The seroprevalence and seroincidence of enterovirus71 infection in infants and children in Ho Chi Minh City, Viet Nam. PLoS One. 2011;6:e21116. 10.1371/journal.pone.0021116</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0021116</ArticleId><ArticleId IdType="pmc">PMC3134465</ArticleId><ArticleId IdType="pubmed">21765891</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons-Salort M, Grassly NC. Serotype-specific immunity explains the incidence of diseases caused by human enteroviruses. Science. 2018;361:800&#x2013;3. 10.1126/science.aat6777</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aat6777</ArticleId><ArticleId IdType="pmc">PMC6559928</ArticleId><ArticleId IdType="pubmed">30139872</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing W, Liao Q, Viboud C, Zhang J, Sun J, Wu JT, et al. Hand, foot, and mouth disease in China, 2008-12: an epidemiological study. Lancet Infect Dis. 2014;14:308&#x2013;18. 10.1016/S1473-3099(13)70342-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(13)70342-6</ArticleId><ArticleId IdType="pmc">PMC4035015</ArticleId><ArticleId IdType="pubmed">24485991</ArticleId></ArticleIdList></Reference><Reference><Citation>Ju Y, Tan Z, Huang H, Chen M, Tan Y, Zhang C, et al. Clinical and epidemiological characteristics of Coxsackievirus A6- and Enterovirus 71-associated clinical stage 2 and 3 severe hand, foot, and mouth disease in Guangxi, Southern China, 2017. J Infect. 2020;80:121&#x2013;42. 10.1016/j.jinf.2019.09.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2019.09.021</ArticleId><ArticleId IdType="pubmed">31629866</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S-C, Chang H-L, Yan T-R, Cheng Y-T, Chen K-T. An eight-year study of epidemiologic features of enterovirus 71 infection in Taiwan. Am J Trop Med Hyg. 2007;77:188&#x2013;91. 10.4269/ajtmh.2007.77.188</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.2007.77.188</ArticleId><ArticleId IdType="pubmed">17620652</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadambari S, Bukasa A, Okike IO, Pebody R, Brown D, Gallimore C, et al. Enterovirus infections in England and Wales, 2000-2011: the impact of increased molecular diagnostics. Clin Microbiol Infect. 2014;20:1289&#x2013;96. 10.1111/1469-0691.12753</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1469-0691.12753</ArticleId><ArticleId IdType="pubmed">25039903</ArticleId></ArticleIdList></Reference><Reference><Citation>Kupila L, Vuorinen T, Vainionp&#xe4;&#x101; R, Marttila RJ, Kotilainen P. Diagnosis of enteroviral meningitis by use of polymerase chain reaction of cerebrospinal fluid, stool, and serum specimens. Clin Infect Dis. 2005;40:982&#x2013;7. 10.1086/428581</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/428581</ArticleId><ArticleId IdType="pubmed">15824990</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvala H, Broberg E, Benschop K, Berginc N, Ladhani S, Susi P, et al. Recommendations for enterovirus diagnostics and characterisation within and beyond Europe. J Clin Virol. 2018;101:11&#x2013;7. 10.1016/j.jcv.2018.01.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2018.01.008</ArticleId><ArticleId IdType="pubmed">29414181</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>